🌍 Epidemiology
Resource-rich: asthma (10-15%), CF (1 in 2500), bronchiolitis. Resource-limited: pneumonia (leading cause child death), TB, pertussis. Environmental: air pollution, passive smoke, overcrowding.
🧬 Fetal programming & genetics
Barker hypothesis: low birthweight → reduced lung function, increased COPD risk. Genetic: CFTR (CF), alpha-1 antitrypsin (emphysema), surfactant proteins (ILD), ADAM33 (asthma).
🌱 Lung development
Embryonic (4-7wk), pseudoglandular (5-17wk), canalicular (16-26wk), saccular (24-38wk), alveolar (36wk-8yr). Surfactant appears ~24wk. Postnatal alveolarisation continues until ~8 years.
📊 Respiratory physiology & PFTs
Spirometry: FEV1, FVC, FEV1/FVC. Lung volumes: TLC, RV, FRC (plethysmography, helium dilution). Airway resistance (oscillometry, interrupter technique). V/Q mismatch (dead space, shunt). DLCO (gas transfer). Breathing control: central/chemoreceptors.
🖥️ Imaging (CXR, CT, MRI, US, nuclear)
CXR: first-line (infections, cardiac, foreign body). CT/HRCT: ILD, bronchiectasis, nodules, pE. MRI: vascular rings, chest wall. US: pleural effusion, lung consolidation, diaphragm. V/Q scan: pulmonary embolism (normal X-ray).
🔍 Airway endoscopy
Flexible bronchoscopy: dynamic airway, BAL, biopsy (indications: stridor, persistent wheeze, recurrent pneumonia, foreign body extraction, hemoptysis). Rigid bronchoscopy: foreign body removal, massive hemoptysis, laser. Safety: sedation/general anaesthesia, monitoring.